Department of Internal Medicine, University Hospital Maastricht, PO Box 5800, 6202, Maastricht, The Netherlands,
Ann Hematol. 2014 May;93(5):811-9. doi: 10.1007/s00277-013-1980-1. Epub 2013 Dec 8.
The objective of this study was to compare health-related quality of life (HRQOL) between diffuse large B cell lymphoma (DLBCL) survivors of different age categories (18-59/60-75/76-85 years) and to compare their HRQOL with an age- and sex-matched normative population. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with DLBCL from 1999 to 2010. Patients (n = 363) were invited to complete the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) questionnaire, and 307 survivors responded (85 %). Data from an age- and sex-matched normative population (n = 596) were used for comparison. DLBCL survivors aged 18-59 years scored better on physical functioning, quality of life, appetite loss and constipation than survivors of 76-85 years old (all p < 0.05). Financial problems more often occurred in survivors aged 18-59 years compared to survivors of 76-85 years old (p < 0.01). Compared to the normative population, DLBCL survivors aged 18-59 years showed worse scores on cognitive and social functioning and on dyspnea and financial problems (p < 0.01, large- and medium-size effects). In survivors of the other age categories, only differences with trivial or small-size effects were found. Although younger DLBCL survivors have better HRQOL than older survivors, the differences found between younger survivors and normative population were the largest. This suggests that having DLBCL has a greater impact on younger than older survivors and that the worse HRQOL observed in older DLBCL survivors in comparison with younger survivors is caused mostly by age itself and not by the disease.
本研究旨在比较不同年龄段(18-59/60-75/76-85 岁)弥漫性大 B 细胞淋巴瘤(DLBCL)幸存者的健康相关生活质量(HRQOL),并将其与年龄和性别匹配的常模人群进行比较。利用基于人群的埃因霍温癌症登记处选择了 1999 年至 2010 年期间所有被诊断为 DLBCL 的患者。邀请患者(n=363)完成欧洲癌症研究与治疗组织生活质量问卷核心 30 项(EORTC QLQ-C30)问卷,共有 307 名幸存者做出回应(85%)。使用来自年龄和性别匹配的常模人群(n=596)的数据进行比较。18-59 岁的 DLBCL 幸存者在身体功能、生活质量、食欲丧失和便秘方面的评分均优于 76-85 岁的幸存者(均 p<0.05)。与 76-85 岁的幸存者相比,18-59 岁的幸存者更经常出现经济问题(p<0.01)。与常模人群相比,18-59 岁的 DLBCL 幸存者在认知和社会功能以及呼吸困难和经济问题方面的评分更差(p<0.01,中到大量效应)。在其他年龄组的幸存者中,仅发现了具有轻微或小效应的差异。尽管年轻的 DLBCL 幸存者的 HRQOL 优于年长的幸存者,但年轻幸存者与常模人群之间的差异最大。这表明 DLBCL 对年轻幸存者的影响大于年长幸存者,而与年轻幸存者相比,年长幸存者的 HRQOL 较差主要是由年龄本身造成的,而不是由疾病造成的。